Is [99mTc]glucarate uptake mediated by fructose transporter GLUT-5?

Nuclear Medicine and Biology

Volumn 39, Issue 8, 2012, Pages 1226-1231

  Isnardi, Vanina ^a   Clotagatide, Anthony ^a   Bruel, Sebastien ^a   Perek, Nathalie ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

99mTc Glucarate tumor cell lines; Fructose GLUT 5 transporter; Oligonucleotides antisense

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; FRUCTOSE; GLUCARATE TC 99M; GLUCOSE TRANSPORTER 5; TRACER; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACCUMULATION; DRUG TRANSPORT; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; TUMOR CELL LINE;

BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; FRUCTOSE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCARIC ACID; GLUCOSE TRANSPORTER TYPE 5; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; ORGANOTECHNETIUM COMPOUNDS;

EID: 84867790735     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2012.07.001     Document Type: Article

References (31)

1. Pak K.Y., Nedelman M.A., Tam S.H., Wilson E., Daddona P.E. Labeling and stability of radiolabeled antibody fragments by a direct 99mTc-labeling method. Int J Rad Appl Instrum B 1992, 19(6):669-677.
2. Yaoita H., Fischman A.J., Wilkinson R., Khaw B.A., Juweid M., Strauss H.W. Distribution of deoxyglucose and technetium-99m-glucarate in the acutely ischemic myocardium. J Nucl Med 1993, 34(8):1303-1308.
3. Yaoita H., Uehara T., Brownell A.L., Rabito C.A., Ahmad M., Khaw B.A., et al. Localization of technetium-99m-glucarate in zones of acute cerebral injury. J Nucl Med 1991, 32(2):272-278.
4. Wiersema A.M., Oyen W.J., Dirksen R., Verhofstad A.A., Corstens F.H., van der Vliet J.A. Early assessment of skeletal muscle damage after ischaemia-reperfusion injury using Tc-99m-glucarate. Cardiovasc Surg 2000, 8(3):186-191.
5. Okada D.R., Johnson G., Liu Z., Hocherman S.D., Khaw B.A., Pak K.Y., et al. Myocardial kinetics of Tc-99m glucarate in low flow, hypoxia, and aglycemia. J Nucl Cardiol 2003, 10(2):168-176.
6. Arteagademurphy C., Ferro-Flores G., Villanueva-Sanchez O., Murphy-Stack E., Pedraza-Lopez M., Melendez-Alafort L., et al. 99mTc-glucarate for detection of isoproterenol-induced myocardial infarction in rats. Int J Pharm 2002, 233(1-2):29-34.
7. Liu Z., Barrett H.H., Stevenson G.D., Kastis G.A., Bettan M., Furenlid L.R., et al. High-resolution imaging with (99m)Tc-glucarate for assessing myocardial injury in rat heart models exposed to different durations of ischemia with reperfusion. J Nucl Med 2004, 45(7):1251-1259.
8. Khaw B.A., Nakazawa A., O'Donnell S.M., Pak K.Y., Narula J. Avidity of technetium 99m glucarate for the necrotic myocardium: in vivo and in vitro assessment. J Nucl Cardiol 1997, 4(4):283-290.
9. Narula J., Petrov A., Pak K.Y., Lister B.C., Khaw B.A. Very early noninvasive detection of acute experimental nonreperfused myocardial infarction with 99mTc-labeled glucarate. Circulation 1997, 95(6):1577-1584.
10. Ballinger J.R., Hsue V., Rauth A.M. Accumulation of technetium-99m glucarate: in vitro cell cultures and in vivo tumour models. Nucl Med Commun 2003, 24(5):597-606.
11. Petrov A.D., Narula J., Nakazawa A., Pak K.Y., Khaw B.A. Targeting human breast tumour in xeno-grafted SCID mice with 99Tcm-glucarate. Nucl Med Commun 1997, 18(3):241-251.
12. Gambini J.P., Nunez M., Cabral P., Lafferranderie M., Noble J., Corchs E., et al. Evaluation of patients with head and neck cancer by means of 99mTc-glucarate. J Nucl Med Technol 2009, 37(4):229-232.
13. Gambini J.P., Cabral P., Alonso O., Savio E., Figueroa S.D., Zhang X., et al. Evaluation of 99mTc-glucarate as a breast cancer imaging agent in a xenograft animal model. Nucl Med Biol 2011, 38(2):255-260.
14. Joost H.G., Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review). Mol Membr Biol 2001, 18(4):247-256.
15. Medina R.A., Owen G.I. Glucose transporters: expression, regulation and cancer. Biol Res 2002, 35(1):9-26.
16. Merrall N.W., Plevin R., Gould G.W. Growth factors, mitogens, oncogenes and the regulation of glucose transport. Cell Signal 1993, 5(6):667-675.
17. Haber R.S., Rathan A., Weiser K.R., Pritsker A., Itzkowitz S.H., Bodian C., et al. GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer 1998, 83(1):34-40.
18. Younes M., Brown R.W., Mody D.R., Fernandez L., Laucirica R. GLUT1 expression in human breast carcinoma: correlation with known prognostic markers. Anticancer Res 1995, 15(6B):2895-2898.
19. Douard V., Ferraris R.P. Regulation of the fructose transporter GLUT5 in health and disease. Am J Physiol Endocrinol Metab 2008, 295(2):E227-E237.
20. Godoy A., Ulloa V., Rodriguez F., Reinicke K., Yanez A.J., Garcia Mde L., et al. Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues. J Cell Physiol 2006, 207(3):614-627.
21. Ito T., Noguchi Y., Satoh S., Hayashi H., Inayama Y., Kitamura H. Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage. Mod Pathol 1998, 11(5):437-443.
22. Kurata T., Oguri T., Isobe T., Ishioka S., Yamakido M. Differential expression of facilitative glucose transporter (GLUT) genes in primary lung cancers and their liver metastases. Jpn J Cancer Res 1999, 90(11):1238-1243.
23. Mahraoui L., Rousset M., Dussaulx E., Darmoul D., Zweibaum A., Brot-Laroche E. Expression and localization of GLUT-5 in Caco-2 cells, human small intestine, and colon. Am J Physiol 1992, 263(3 Pt 1):G312-G318.
24. Zamora-Leon S.P., Golde D.W., Concha I.I., Rivas C.I., Delgado-Lopez F., Baselga J., et al. Expression of the fructose transporter GLUT5 in human breast cancer. Proc Natl Acad Sci USA 1996, 93(5):1847-1852.
25. Beauchesne P., Bertrand S., N'Guyen M.J., Christianson T., Dore J.F., Mornex F., et al. Etoposide sensitivity of radioresistant human glioma cell lines. Cancer Chemother Pharmacol 1998, 41(2):93-97.
26. Chan K.K., Chan J.Y., Chung K.K., Fung K.P. Inhibition of cell proliferation in human breast tumor cells by antisense oligonucleotides against facilitative glucose transporter 5. J Cell Biochem 2004, 93(6):1134-1142.
27. Heiser P., Singh S., Krieg J.C., Vedder H. Effects of different antipsychotics and the antidepressant mirtazapine on glucose transporter mRNA levels in human blood cells. J Psychiatr Res 2006, 40(4):374-379.
28. Perek N., Sabido O., Le Jeune N., Prevot N., Vergnon J.M., Clotagatide A., et al. Could 99mTc-glucarate be used to evaluate tumour necrosis? In vitro and in vivo studies in leukaemic tumour cell line U937. Eur J Nucl Med Mol Imaging 2008, 35(7):1290-1298.
29. Perek N., Le Jeune N., Denoyer D., Dubois F. MRP-1 protein expression and glutathione content of in vitro tumor cell lines derived from human glioma carcinoma U-87-MG do not interact with 99mTc-glucarate uptake. Cancer Biother Radiopharm 2005, 20(4):391-400.
30. Haradahira T., Tanaka A., Maeda M., Kanazawa Y., Ichiya Y.I., Masuda K. Radiosynthesis, rodent biodistribution, and metabolism of 1-deoxy-1-[18F]fluoro-D-fructose. Nucl Med Biol 1995, 22(6):719-725.
31. Wuest M., Trayner B.J., Grant T.N., Jans H.S., Mercer J.R., Murray D., et al. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer. Nucl Med Biol 2011, 38(4):461-475.